FDA clears exoskeleton for stroke rehabilitation
The U.S. Food and Drug Administration has cleared Wandercraft's self-balancing exoskeleton for use in stroke rehabilitation. In July 2021, Reuters was given a first-hand demonstration of the possibilities wearable exoskeletons can have for people with disabilities.
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook